3-BROMO-2-METHYLPROPYL ACETATE, 95.0%, 1g

(S)-1-Methyl-3-pyrrolidinol>98.0%(GC)(T)1g

(S)-2-CYANOPYRROLIDINE TFA, 95.0%, 5g

6-Bromo-2-fluoro-3-propoxybenzaldehyde, 95+%, 10g

Piano obiettivo per contrasto di fase PLPH S100x/1,25

5-Cyclobutyl-4H-1,2,4-triazol-3-ylamine, 95.0%, 5g

7-methoxy-6-nitro-1,4-dihydroquinazolin-4-one, 97%, 100mg

6-Chloro-2H-1-benzopyran-3-carboxylic acid, 95.0%, 1g

n-(2,2-Diethoxyethyl)aniline, 95+%, 250mg

7-IODO-1H-INDAZOLE, 95%, 5g

2-Morpholinoethanol, 95.0%, 25g

1-[4-(Trifluoromethyl)pyrimid-2-yl]homopiperazine, 97.0%, 1g

2-Bromo-5-chloro-4-fluoroiodobenzene, 5g